III.14.e.i—Access Restrictions During Blinded Studies
>Control Description
To ensure objectivity in many clinical trials, participants, and often investigators as well, cannot be given access to information about which treatment each participant may be receiving. Doing so would jeopardize the validity of the research study and results. Participants in such clinical trials (referred to as 'blinded' studies) do not have to be provided access to the data on their treatment during the trial if this restriction has been explained when the participant entered the trial and the disclosure of such information would jeopardize the integrity of the research effort.
>Cross-Framework Mappings
Ask AI
Configure your API key to use AI features.